{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T02:54:25Z","timestamp":1785034465333,"version":"3.55.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.00286","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T16:10:47Z","timestamp":1585671047000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Role of Alterations in Protein Kinase p38\u03b3 in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and \u03b1-Synuclein Transgenic Models"],"prefix":"10.3389","volume":"14","author":[{"given":"Michiyo","family":"Iba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazmin","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Adame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Rockenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somin","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/B978-0-12-802395-2.00024-9","article-title":"Alpha-synucleinopathies.","volume":"145","author":"Alafuzoff","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.14283\/jpad.2017.41","article-title":"Neflamapimod: clinical Phase 2b-ready oral small molecule inhibitor of p38alpha to reverse synaptic dysfunction in early Alzheimer\u2019s disease.","volume":"4","author":"Alam","year":"2017","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri1865","article-title":"The many paths to p38 mitogen-activated protein kinase activation in the immune system.","volume":"6","author":"Ashwell","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"11116","DOI":"10.1073\/pnas.1903054116","article-title":"Synapsins regulate alpha-synuclein functions.","volume":"116","author":"Atias","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B5","first-page":"199","article-title":"The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS.","volume":"1","author":"Bachstetter","year":"2010","journal-title":"Aging Dis."},{"key":"B6","doi-asserted-by":"crossref","first-page":"10454","DOI":"10.1128\/MCB.25.23.10454-10464.2005","article-title":"Generation and characterization of p38beta (MAPK11) gene-targeted mice.","volume":"25","author":"Beardmore","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12562","article-title":"Syntrophins entangled in cytoskeletal meshwork: helping to hold it all together.","volume":"52","author":"Bhat","year":"2019","journal-title":"Cell Prolif."},{"key":"B8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","article-title":"A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201dLine 61\u201d) mice.","volume":"9","author":"Chesselet","year":"2012","journal-title":"Neurotherapeutics"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152355","article-title":"alpha1-Syntrophin Variant identified in drug-induced long QT syndrome increases late sodium current.","volume":"11","author":"Choi","year":"2016","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/649079","article-title":"The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease.","volume":"2012","author":"Correa","year":"2012","journal-title":"J. Signal. Transduct."},{"key":"B11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12640-009-9073-6","article-title":"Role of synucleins in Alzheimer\u2019s disease.","volume":"16","author":"Crews","year":"2009","journal-title":"Neurotox Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jalz.2015.12.005","article-title":"Meta-analysis of synaptic pathology in Alzheimer\u2019s disease reveals selective molecular vesicular machinery vulnerability.","volume":"12","author":"de Wilde","year":"2016","journal-title":"Alzheimers Dement."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075025","article-title":"Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer\u2019s diseases.","volume":"8","author":"Duka","year":"2013","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.nbd.2017.05.002","article-title":"Differential effects of immunotherapy with antibodies targeting alpha-synuclein oligomers and fibrils in a transgenic model of synucleinopathy.","volume":"104","author":"El-Agnaf","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2016.00031","article-title":"p38gamma and p38delta mitogen activated protein kinases (MAPKs). new stars in the MAPK Galaxy.","volume":"4","author":"Escos","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04232-4","article-title":"Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson\u2019s disease.","volume":"7","author":"Fang","year":"2017","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/mds.27647","article-title":"Endosomal trafficking leads the way in Parkinson\u2019s disease.","volume":"34","author":"Farrer","year":"2019","journal-title":"Mov. Disord."},{"key":"B18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1242\/jcs.01655","article-title":"Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4\/p38delta at Thr50 promotes microtubule assembly.","volume":"118","author":"Feijoo","year":"2005","journal-title":"J. Cell Sci."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-018-0835-5","article-title":"Lewy body disease: clinical and pathological \u201cOverlap Syndrome\u201d between synucleinopathies (Parkinson Disease) and tauopathies (Alzheimer Disease).","volume":"18","author":"Foguem","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","article-title":"Synucleinopathies: clinical and pathological implications.","volume":"58","author":"Galvin","year":"2001","journal-title":"Arch. Neurol."},{"key":"B21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(97)00483-3","article-title":"Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases.","volume":"409","author":"Goedert","year":"1997","journal-title":"FEBS Lett;"},{"key":"B22","doi-asserted-by":"crossref","first-page":"12626","DOI":"10.1074\/jbc.274.18.12626","article-title":"Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition.","volume":"274","author":"Hasegawa","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1515\/tnsci-2018-0022","article-title":"P38 mitogen-activated protein kinase and Parkinson\u2019s Disease.","volume":"9","author":"He","year":"2018","journal-title":"Transl. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/mds.27773","article-title":"Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.","volume":"34","author":"Heckman","year":"2019","journal-title":"Mov. Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol."},{"key":"B26","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.aah6205","article-title":"Site-specific phosphorylation of tau inhibits amyloid-beta toxicity in Alzheimer\u2019s mice.","volume":"354","author":"Ittner","year":"2016","journal-title":"Science"},{"key":"B27","first-page":"67","article-title":"p38 MAPK and PI3K\/AKT Signalling Cascades inParkinson\u2019s Disease.","volume":"4","author":"Jha","year":"2015","journal-title":"Int. J. Mol. Cell Med."},{"key":"B28","doi-asserted-by":"crossref","first-page":"30122","DOI":"10.1074\/jbc.272.48.30122","article-title":"Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta.","volume":"272","author":"Jiang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"12500","DOI":"10.1523\/JNEUROSCI.4511-08.2008","article-title":"Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.","volume":"28","author":"Karunakaran","year":"2008","journal-title":"J. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1515\/revneuro-2018-0008","article-title":"Role of p38\/MAPKs in Alzheimer\u2019s disease: implications for amyloid beta toxicity targeted therapy.","volume":"30","author":"Kheiri","year":"2018","journal-title":"Rev. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.celrep.2015.09.044","article-title":"Antagonizing neuronal toll-like receptor 2 prevents synucleinopathy by activating autophagy.","volume":"13","author":"Kim","year":"2015","journal-title":"Cell Rep."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0276-2","article-title":"Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating alpha-synuclein transmission and neuroinflammation.","volume":"13","author":"Kim","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"B34","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: an update.","volume":"89","author":"Kim","year":"2015","journal-title":"Arch. Toxicol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5607\/en.2019.28.5.547","article-title":"Targeting microglial and neuronal toll-like receptor 2 in synucleinopathies.","volume":"28","author":"Kwon","year":"2019","journal-title":"Exp. Neurobiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target.","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22081287","article-title":"Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer\u2019s Disease.","volume":"22","author":"Lee","year":"2017","journal-title":"Molecules"},{"key":"B38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/(SICI)1097-4547(20000601)60:5<623::AID-JNR7>3.0.CO;2-4","article-title":"Constitutive activity and differential localization of p38alpha and p38beta MAPKs in adult mouse brain.","volume":"60","author":"Lee","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.biocel.2010.07.016","article-title":"Tau protein: relevance to Parkinson\u2019s disease.","volume":"42","author":"Lei","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/mds.27385","article-title":"Full sequencing and haplotype analysis of MAPT in Parkinson\u2019s disease and rapid eye movement sleep behavior disorder.","volume":"33","author":"Li","year":"2018","journal-title":"Mov. Disord."},{"key":"B41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2015.02.028","article-title":"Molecular mechanisms linking amyloid beta toxicity and Tau hyperphosphorylation in Alzheimers disease.","volume":"83","author":"Lloret","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nn.4529","article-title":"alpha-Synuclein promotes dilation of the exocytotic fusion pore.","volume":"20","author":"Logan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-016-0221-y","article-title":"Selective suppression of the alpha isoform of p38 MAPK rescues late-stage tau pathology.","volume":"8","author":"Maphis","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"B44","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0006-8993(00)03063-8","article-title":"Immunolocalization of p38 MAP kinase in mouse brain.","volume":"887","author":"Maruyama","year":"2000","journal-title":"Brain Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/S1353-8020(13)70017-8","article-title":"alpha-Synucleinopathy phenotypes.","volume":"20","author":"McCann","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"B46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium.","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"B47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-5793(96)00255-4","article-title":"SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases.","volume":"383","author":"Mertens","year":"1996","journal-title":"FEBS Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/15548627.2017.1395992","article-title":"Autophagy inhibition promotes SNCA\/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype.","volume":"14","author":"Minakaki","year":"2018","journal-title":"Autophagy"},{"key":"B49","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neuint.2017.12.011","article-title":"A refined concept: alpha-synuclein dysregulation disease.","volume":"119","author":"Mochizuki","year":"2018","journal-title":"Neurochem. Int."},{"key":"B50","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.","volume":"20","author":"Mucke","year":"2000","journal-title":"J. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"15596","DOI":"10.1523\/JNEUROSCI.5195-12.2013","article-title":"Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice.","volume":"33","author":"Nagahara","year":"2013","journal-title":"J. Neurosci\/"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0445-5","article-title":"Brain-derived exosomes from dementia with Lewy bodies propagate alpha-synuclein pathology.","volume":"5","author":"Ngolab","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0273-5","article-title":"A new hypothesis for Parkinson\u2019s disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics.","volume":"13","author":"Obergasteiger","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"B54","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.bcp.2014.01.015","article-title":"Pathogenesis of synaptic degeneration in Alzheimer\u2019s disease and Lewy body disease.","volume":"88","author":"Overk","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1177\/1179069518796215","article-title":"Sorting out the role of alpha-synuclein in retromer-mediated endosomal protein sorting.","volume":"12","author":"Patel","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1533317507310565","article-title":"Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies.","volume":"23","author":"Revuelta","year":"2008","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"B57","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease.","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"B58","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/brain\/awu057","article-title":"Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in vivo.","volume":"137","author":"Rockenstein","year":"2014","journal-title":"Brain"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121570","article-title":"A novel triple repeat mutant tau transgenic model that mimics aspects of pick\u2019s disease and fronto-temporal tauopathies.","volume":"10","author":"Rockenstein","year":"2015","journal-title":"PLoS One"},{"key":"B61","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/sj.emboj.7600578","article-title":"p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP.","volume":"24","author":"Sabio","year":"2005","journal-title":"EMBO J."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47227-z","article-title":"Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders.","volume":"9","author":"Schaser","year":"2019","journal-title":"Sci. Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia.","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00401-011-0843-x","article-title":"Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Abeta and tau pathology in transgenic mouse models of Alzheimer\u2019s disease.","volume":"122","author":"Shao","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"7971","DOI":"10.1523\/JNEUROSCI.0775-16.2016","article-title":"Reducing endogenous alpha-synuclein mitigates the degeneration of selective neuronal populations in an alzheimer\u2019s disease transgenic mouse model.","volume":"36","author":"Spencer","year":"2016","journal-title":"J. Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jnc.14810","article-title":"The physiological role of alpha-synuclein and its relationship to Parkinson\u2019s Disease.","volume":"150","author":"Sulzer","year":"2019","journal-title":"J. Neurochem."},{"key":"B67","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0014-4886(03)00180-8","article-title":"P38 MAP kinase is activated at early stages in Alzheimer\u2019s disease brain.","volume":"183","author":"Sun","year":"2003","journal-title":"Exp. Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1073\/pnas.1903049116","article-title":"Functional cooperation of alpha-synuclein and VAMP2 in synaptic vesicle recycling.","volume":"116","author":"Sun","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B69","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neulet.2010.09.016","article-title":"Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease.","volume":"485","author":"Ubhi","year":"2010","journal-title":"Neurosci. Lett."},{"key":"B70","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/jnc.13249","article-title":"Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.","volume":"139","author":"Villar-Pique","year":"2016","journal-title":"J. Neurochem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.nbd.2016.12.008","article-title":"Effects of alpha-synuclein on axonal transport.","volume":"105","author":"Volpicelli-Daley","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"B72","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide pleiotropy between parkinson disease and autoimmune diseases.","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"key":"B73","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/brain\/aww238","article-title":"A de novo compound targeting alpha-synuclein improves deficits in models of Parkinson\u2019s disease.","volume":"139","author":"Wrasidlo","year":"2016","journal-title":"Brain"},{"key":"B74","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12031-014-0372-x","article-title":"Inhibition of neuronal p38alpha, but not p38beta MAPK, provides neuroprotection against three different neurotoxic insults.","volume":"55","author":"Xing","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3969\/j.issn.1673-5374.2012.14.007","article-title":"Inhibiting p38 mitogen-activated protein kinase attenuates cerebral ischemic injury in Swedish mutant amyloid precursor protein transgenic mice.","volume":"7","author":"Zou","year":"2012","journal-title":"Neural. Regen. Res."}],"updated-by":[{"DOI":"10.3389\/fnins.2025.1721408","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000}},{"DOI":"10.3389\/fnins.2025.1721408","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"record-id":"69893"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00286\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T16:10:57Z","timestamp":1585671057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00286\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":75,"alternative-id":["10.3389\/fnins.2020.00286"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.00286","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"article-number":"286"}}